Tune in to the latest in our Drug Safety Matters Long Reads series, exploring how pharmacovigilance experts can help win the war on viral misinformation – by not fighting it.
Communications / 29 March 2021
Email newsletter are back in style. And for health communicators in a time of pandemic, one could argue that they have have never been more useful.
Communications / 29 March 2021
As the COVID-19 pandemic spread around the world, so did wave of viral misinformation. For pharmacovigilance, fighting the “infodemic” is a massive, but necessary, battle.
Communications / 18 December 2020
The new episode of the Drug Safety Matters podcast is here. Find why pharmacovigilance scientists should not discount the value of intuition.
Communications / 18 December 2020
Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.